Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00425815
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Withdrawn Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Org 24448;   Other: Placebo

Indicates status has not been verified in more than two years